A randomized feasibility pilot-study of intravenous and subcutaneous administration of ketamine to prevent postpartum depression after planned cesarean delivery under neuraxial anesthesia
Abstract Background Evidence suggests ketamine may prevent postpartum depression (PPD) after cesarean delivery (CD) although intolerability and inconvenience of administration are problematic. We assessed the feasibility of studying ketamine (0.5 mg/kg, via subcutaneous injection or 40-min intraveno...
Main Authors: | David Thomas Monks, Arvind Palanisamy, Danish Jaffer, Preet Mohinder Singh, Ebony Carter, Shannon Lenze |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12884-022-05118-8 |
Similar Items
-
Intraoperative ketamine for reduction in postpartum depressive symptoms after cesarean delivery: A double‐blind, randomized clinical trial
by: Jiaxin Yao, et al.
Published: (2020-09-01) -
Single low-dose ketamine infusion for women with prenatal depressive symptoms undergoing cesarean delivery: A pilot randomized trial
by: Shuo Wang, et al.
Published: (2022-12-01) -
S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial
by: Yaqian Han, et al.
Published: (2022-02-01) -
The Effect of Subcutaneous Ketamine Infiltration on Postoperative Pain in Elective Cesarean Section under Spinal Anesthesia
by: Nahid Manouchehrian, et al.
Published: (2015-03-01) -
Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail
by: Shixia Xu, et al.
Published: (2024-01-01)